Regeneron is a leading biotechnology company that invents, develops, and commercializes medicines for people with serious diseases. Founded and led for 35+ years by physician-scientists, Regeneron’s unique ability to translate science into medicine has led to numerous FDA-approved treatments and product candidates in development. Regeneron’s medicines and pipeline are designed to help patients, including patients with certain types of serious eye diseases.
For more information, please visit www.regeneron.com or follow us on LinkedIn, Instagram, Facebook, or X.
Website: https://www.regeneron.com
Any inquires please reach out to medical.information@regeneron.com
Perspectives on Ophthalmology Innovation | Regeneron Stories